UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interpretation and use of FRAX in clinical practice

Osteoporosis international, 2011-09, Vol.22 (9), p.2395-2411

2011

Volltextzugriff (PDF)

Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures

Osteoporosis international, 2022-07, Vol.33 (7), p.1511-1519

2022

Volltextzugriff (PDF)

Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls

European journal of endocrinology, 2010-11, Vol.163 (5), p.833-837

2010

Volltextzugriff (PDF)

Sclerostin: Current Knowledge and Future Perspectives

Calcified tissue international, 2010-08, Vol.87 (2), p.99-107

2010

Volltextzugriff (PDF)

Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site

Osteoporosis international, 2017-08, Vol.28 (8), p.2433-2437

2017

Volltextzugriff (PDF)

Denosumab for the treatment of primary pediatric osteoporosis

Osteoporosis international, 2021-11, Vol.32 (11), p.2377-2381

2021

Volltextzugriff (PDF)

Sclerostin in Mineralized Matrices and van Buchem Disease

Journal of dental research, 2009-06, Vol.88 (6), p.569-574

2009

Volltextzugriff (PDF)

Serum Dickkopf 1 Levels in Sclerostin Deficiency

The journal of clinical endocrinology and metabolism, 2014-02, Vol.99 (2), p.E252-E256

2014

Volltextzugriff (PDF)

Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates

Bone (New York, N.Y.), 2003-11, Vol.33 (5), p.805-811

2003

Volltextzugriff (PDF)

Circulating Sclerostin Levels Are Decreased in Patients with Endogenous Hypercortisolism and Increase after Treatment

The journal of clinical endocrinology and metabolism, 2012-10, Vol.97 (10), p.E1953-E1957

2012

Volltextzugriff (PDF)

Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus

European journal of endocrinology, 2012-04, Vol.166 (4), p.711-716

2012

Volltextzugriff (PDF)

Exposure of KS483 Cells to Estrogen Enhances Osteogenesis and Inhibits Adipogenesis

Journal of bone and mineral research, 2002-03, Vol.17 (3), p.394-405

2002

Volltextzugriff (PDF)

Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate

Annals of the Rheumatic Diseases, 2008-06, Vol.84 (992), p.307-858

2008

Volltextzugriff (PDF)

Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis

Bone (New York, N.Y.), 2005-11, Vol.37 (5), p.651-654

2005

Volltextzugriff (PDF)

Spine radiographs to improve the identification of women at high risk for fractures

Osteoporosis international, 2009-08, Vol.20 (8), p.1347-1352

2009

Volltextzugriff (PDF)

Interleukin 17 synergises with tumour necrosis factor α to induce cartilage destruction in vitro

Annals of the rheumatic diseases, 2002-10, Vol.61 (10), p.870-876

2002

Volltextzugriff (PDF)

Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials

International journal of clinical practice (Esher), 2010-05, Vol.64 (6), p.821-826

2010

Volltextzugriff (PDF)

Synergistic effect of bisphosphonate and docetaxel on the growth of bone metastasis in an animal model of established metastatic bone disease

Breast cancer research and treatment, 2009-11, Vol.118 (2), p.307-313

2009

Volltextzugriff (PDF)

Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis

Bone (New York, N.Y.), 2009-05, Vol.44 (5), p.766-771

2009

Volltextzugriff (PDF)

Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells : The role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors

Bone (New York, N.Y.), 2002, Vol.30 (1), p.64-70

2002

Volltextzugriff (PDF)

Treatments of osteoporosis increase bone material strength index in patients with low bone mass

Osteoporosis international, 2020-09, Vol.31 (9), p.1683-1690

2020

Volltextzugriff (PDF)

A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men

Bone (New York, N.Y.), 2002-11, Vol.31 (5), p.556-561

2002

Volltextzugriff (PDF)

Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships

Bone (New York, N.Y.), 1998-11, Vol.23 (5), p.437-442

1998

Volltextzugriff (PDF)

Interleukin‐17: A New Bone Acting Cytokine In Vitro

Journal of bone and mineral research, 1999-09, Vol.14 (9), p.1513-1521

1999

Volltextzugriff (PDF)

A rare cause of facial nerve palsy in children: Hyperostosis corticalis generalisata (Van Buchem disease). Three new pediatric cases and a literature review

European journal of paediatric neurology, 2012-11, Vol.16 (6), p.740-743

2012

Volltextzugriff (PDF)

1 – 25 von 564

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(375)
Mit Volltextzugriff
(471)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(249)
Life Sciences & Biomedicine
(248)
Humans
(246)
Female
(154)
Biological And Medical Sciences
(152)
Endocrinology & Metabolism
(148)
Medical Sciences
(119)
Male
(110)
Middle Aged
(108)
Osteoporosis
(96)
Aged
(85)
Adult
(74)
Animals
(71)
Diphosphonates - Therapeutic Use
(57)
Fundamental And Applied Biological Sciences. Psychology
(51)
Bisphosphonates
(50)
Pharmacology. Drug Treatments
(49)
Mice
(48)
General & Internal Medicine
(46)
Orthopedics
(42)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Interpretation and use of FRAX in clinical practice

Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures

Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls

Sclerostin: Current Knowledge and Future Perspectives

Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site

Denosumab for the treatment of primary pediatric osteoporosis

Sclerostin in Mineralized Matrices and van Buchem Disease

Serum Dickkopf 1 Levels in Sclerostin Deficiency

Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates

Circulating Sclerostin Levels Are Decreased in Patients with Endogenous Hypercortisolism and Increase after Treatment

Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus

Exposure of KS483 Cells to Estrogen Enhances Osteogenesis and Inhibits Adipogenesis

Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate

Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis

Spine radiographs to improve the identification of women at high risk for fractures

Interleukin 17 synergises with tumour necrosis factor α to induce cartilage destruction in vitro

Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials

Synergistic effect of bisphosphonate and docetaxel on the growth of bone metastasis in an animal model of established metastatic bone disease

Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis

Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells : The role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors

Treatments of osteoporosis increase bone material strength index in patients with low bone mass

A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men

Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships

Interleukin‐17: A New Bone Acting Cytokine In Vitro

A rare cause of facial nerve palsy in children: Hyperostosis corticalis generalisata (Van Buchem disease). Three new pediatric cases and a literature review

Suchergebnisse filtern